Agustin Melian - 28 Sep 2021 Form 4 Insider Report for Allovir, Inc. (KLRS)

Role
Chief Medical Officer
Signature
/s/ Brett Hagen, as Attorney-in-Fact
Issuer symbol
KLRS
Transactions as of
28 Sep 2021
Net transactions value
-$90,432
Form type
4
Filing time
29 Sep 2021, 16:15:21 UTC
Previous filing
20 Sep 2021
Next filing
05 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALVR Common Stock Sale $90,432 -3,750 -0.79% $24.12* 472,218 28 Sep 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.23. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.